Recherche
-
Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery
(Scientific Reports. vol. 14, n° 1, pp. 934, 2024-01-09)Article de revueLibre accès -
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
(International Journal of Epidemiology. vol. 53, n° 1, 2024-02-01)Article de revueLibre accès -
Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)
(Scientific Reports. vol. 13, n° 1, pp. 16535, 2023-10-02)Article de revueLibre accès -
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
(PLoS Neglected Tropical Diseases. vol. 18, n° 4, pp. e0011500, 2024-04-11)Article de revueLibre accès -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueLibre accès -
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART
(International Journal of Infectious Diseases. vol. 146, pp. 107110, 2024-05-31)Article de revueLibre accès -
Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption
(Clinical Infectious Diseases. pp. ciae235, 2024-05-31)Article de revue -
CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study)
(European Journal of Clinical Microbiology & Infectious Diseases, 2024-03-26)Article de revueLibre accès -
Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report
(Infectious Disease Modelling. vol. 9, n° 2, pp. 501-518, 2024-06-01)Article de revueLibre accès -
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol
(BMC Infectious Diseases. vol. 24, n° 1, pp. 329, 2024-03-19)Article de revueLibre accès